TD Asset Management »

Intra Cellular Therapies shares owned by TD Asset Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.2M 73k 71.62
2020-09-30 $434k 17k 25.66
2020-06-30 $599k 23k 25.68
2020-03-31 $549k 36k 15.37
2019-12-31 $1.0M 30k 34.30
2019-06-30 $193k 15k 12.95
2019-03-31 $173k 14k 12.18
2018-12-31 $162k 14k 11.41
2018-09-30 $458k 21k 21.71
2018-06-30 $666k 38k 17.67
2018-03-31 $1.0M 49k 21.06
2017-03-31 $228k 14k 16.29
2016-12-31 $231k 15k 15.10
2016-09-30 $216k 14k 15.21